# China NMPA Product Recall - Patient monitor

Source: https://www.globalkeysolutions.net/records/china_product_recall/ge-healthcare-china-co-ltd/5189d085-8899-474f-9ac5-2c08cd3c95d4/
Source feed: China

> China NMPA product recall for Patient monitor by GE Healthcare (China) Co., Ltd. published November 26, 2012. Recall level: Level 1 Recall. On November 26, 2012, the National Medical Products Administration (NMPA) announced a Level 1 recall

---

## Details

- Record Type: CHINA_PRODUCT_RECALL
- Title: GE Healthcare recalls patient monitors
- Company Name: GE Healthcare (China) Co., Ltd.
- Publication Date: 2012-11-26
- Product Name: Patient monitor
- Recall Level: Level 1 Recall
- Recall Reason: The “V Tachy” and “V Fib” alarm functions of the monitor B20 do not work in neonatal mode, which may result in missed alarms for fatal arrhythmias, potentially leading to serious accidents. Other modes and parameters are unaffected.
- Discovering Company: GE Healthcare Systems Trade Development (Shanghai) Co., Ltd.
- Manufacturing Company: GE Healthcare (China) Co., Ltd.
- Summary: On November 26, 2012, the National Medical Products Administration (NMPA) announced a Level 1 recall initiated by GE Healthcare for specific batches of its Patient Monitors (Model B20), registered as SuShiYaoJianXie(Zhun)Zi 2011 No. 2210950. The recall, reported by GE Healthcare Systems Trade Development (Shanghai) Co., Ltd. on November 5, 2012, addresses a critical safety concern: the "V Tachy" and "V Fib" alarm functions in these devices may fail to activate in neonatal mode. This malfunction could lead to missed alarms for fatal arrhythmias, posing a risk of serious adverse events for neonates. The recall affects 1140 units, with 152 already installed in healthcare facilities across various regions. GE Healthcare has reported no customer complaints or actual serious injuries/deaths related to this specific issue at the time of the recall. To rectify the problem and ensure patient safety, GE Healthcare is implementing two primary corrective actions. Firstly, the company is issuing user notifications to inform all affected customers about the identified software anomaly. Secondly, service engineers are conducting on-site software upgrades for all installed units to restore the proper functionality of the arrhythmia alarms in neonatal mode. The NMPA has instructed provincial, autonomous region, and municipal food and drug administrations to enhance their oversight of these products.

Company: https://www.globalkeysolutions.net/companies/ge-healthcare-china-co-ltd/54e52bc9-beef-4ac4-a7d7-a5f2c9dbe214/